News of their birth prompted global condemnation of the work,
raising the ethical specter of so-called designer babies in which
embryos could be genetically modified to produce children with
desirable traits.
The scientists and ethicists want to halt genetic alterations of "germline
cells" - egg or sperm cells - that can then be inherited by others
and "could have permanent and possibly harmful effects on the
species."
The global moratorium would be in place until nations can devise
international principles to guide how the technology should be used,
the experts wrote in the journal Nature. It would not cover gene
editing done in embryos for research purposes that would not lead to
a live birth.
“The governance framework we are calling for will place major speed
bumps in front of the most adventurous plans to re-engineer the
human species,” the experts said in a commentary in the Nature. "The
introduction of genetic modifications into future generations could
have permanent and possibly harmful effects on the species,” they
wrote.
Such work differs from research being conducted by numerous drug
companies and scientists into gene therapies based on editing
so-called somatic cells that affect an individual's health by
correcting a disease or condition but would not be passed on to
offspring.
Dr. Francis Collins, director of the U.S. National Institutes of
Health, said in a letter to the journal that the "NIH strongly
agrees" that a ban on the practice should go into immediate effect
and stay in place until nations can commit to international rules to
determine "whether and under what conditions such research should
ever proceed."
[to top of second column] |
“There is no doubt that genome editing technologies hold huge
potential," Collins said, but added that there are too many
scientific and ethical questions that need to be answered.
Some scientists called the proposed ban unnecessary, saying it would
not prevent a scientist bent on using the technology from editing
DNA in embryos to prevent disease or enhance traits of a child, as
was the case with Chinese researcher He Jiankui.
“We do not think a moratorium would have deterred He Jiankui, who
acted secretively and in breach of a clear scientific consensus that
germline genome editing should not be used in the clinic at this
time,” Sarah Norcross, director of Britain-based Progress
Educational Trust, said in a statement.
Helen O'Neill, program director for Reproductive Science and Women's
Health at University College London, said the proposal ignores the
fact that a global ban already exists.
O'Neill said there were legal and ethical measures in place in China
and that He broke many of these rules. "It was not that he did this
because the law allowed it."
(Reporting by Julie Steenhuysen; additional reporting by Kate
Kelland in London; editing by Bill Berkrot)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|